Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapy

8 Jul 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Cancer Treatment Studies
Share to Cancer Cells and Metastasis
Share to Metastasis and carcinoma case studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23835592
DOI: 10.1007/s10735-013-9523-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD44/CD24 as potential prognostic markers in node-positive invasive ductal breast cancer patients treated with adjuvant chemotherapyPMID 23835592Read ↗

Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.Semantic proximity Read ↗

[CD44 as a prognostic factor of breast cancers].Semantic proximity Read ↗

Prognosis assessment of CD44+/CD24- in Breast Cancer Patients: a systematic review and meta-analysisSemantic proximity Read ↗

CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.Semantic proximity Read ↗

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast CancerSemantic proximity Read ↗

Prognostic molecular markers and neoadjuvant therapy response in anthracycline-treated breast cancer patientsSemantic proximity Read ↗

Prognostic value of CD44 splice variants in human stage III cervical cancerSemantic proximity Read ↗

The CD44+/CD24- phenotype relates to 'triple-negative' state and unfavorable prognosis in breast cancer patients.Semantic proximity Read ↗

Current status of CD44 variant isoforms as cancer diagnostic markers.Semantic proximity Read ↗

MDM2 protein expression is a negative prognostic marker in breast carcinomaSemantic proximity Read ↗

Isolation of CD24high and CD24low/− cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7Semantic proximity Read ↗

Prognostic value of PIK3CA mutation status, PTEN and androgen receptor expression for metastasis-free survival in HER2-positive breast cancer patients treated with trastuzumab in adjuvant setting.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.